Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INcrétines et REModelage OSseux

NCT03966261 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT03966261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03966261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INcrétines et REModelage OSseux
Lead sponsor
University Hospital, Angers
Phase
Observational
Overall status
Terminated
Start date
March 10, 2020
Completion date
May 2, 2022
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone remodeling, healthy, incretins, osteoporosis